NCT02315066 Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566 Status COMPLETED Phase PHASE1
NCT02312037 Expanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative Therapy Status NO_LONGER_AVAILABLE Phase N/A
NCT02311946 A Pilot Study To Investigate The Effect Of Concurrent Antacid Administration On The Bioavailability Of Six Experimental Formulations Of Palbociclib Status COMPLETED Phase PHASE1
NCT02311842 To Investigate Genetic Factors Associated With the Response to Anti-TNF Therapy in Patients With Early AS Status COMPLETED Phase N/A
NCT02311777 Pre-operative Pregabalin and Ketamine to Prevent Phantom Pain Status WITHDRAWN Phase PHASE3
NCT02310763 A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of PF-06252616 in Duchenne Muscular Dystrophy Status TERMINATED Phase PHASE2
NCT02310750 A Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06700841, With Bioavailability/Food Effect Investigation Status COMPLETED Phase PHASE1
NCT02310568 POC Study in Partially Responsive Generalized Anxiety Disorder Status TERMINATED Phase PHASE2
NCT02310243 Study of Palbociclib in MLL-rearranged Acute Leukemias Status UNKNOWN Phase PHASE1/PHASE2
NCT02309827 Safety and Pharmacokinetic Study of PF-06651600 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02307825 Azithromycin for Patients With Chronic Rhinosinusitis Failing Medical and Surgical Therapy Status COMPLETED Phase PHASE4
NCT02306876 A Study To Examine Safety, Pharmacokinetics, And Pharmacodynamic Of Pf 06412562 In Healthy Males Status TERMINATED Phase PHASE1
NCT02304406 Retrospective Epidemiology Study Of ALK Rearrangement In Non-Small Cell Lung Cancer Patients In The Middle East & North Africa Status COMPLETED Phase N/A
NCT02300519 Thrombin Generation Numerical Models Validation in Haemophilic Case Status COMPLETED Phase N/A
NCT02299635 A Study Evaluating PF-03084014 In Patients With Advanced Breast Cancer With Or Without Notch Alterations Status TERMINATED Phase PHASE2
NCT02297438 A Study Of Palbociclib (PD-0332991) + Letrozole VS. Placebo+ Letrozole For 1st Line Treatment Of Asian Postmenopausal Women With ER+/HER2- Advanced Breast Cancer [PALOMA-4] Status COMPLETED Phase PHASE3
NCT02297425 A Study For Patients With EGFRm (Epidermal Growth Factor Receptor Mutant) Lung Cancer Status WITHDRAWN Phase PHASE2
NCT02296801 A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast Cancer Status COMPLETED Phase PHASE2
NCT02292433 A Phase 1 Study In Japanese Subjects With Type 2 Diabetes Mellitus As Monotherapy Status COMPLETED Phase PHASE1